Elsevier

Brain Research

Volume 493, Issue 2, 31 July 1989, Pages 247-257
Brain Research

Decreased striatal D1 binding density following mesotelencephalic 6-hydroxydopamine injections: an autoradiographic analysis

https://doi.org/10.1016/0006-8993(89)91160-8Get rights and content

Abstract

Autoradiographic experiments performed on rats with unilateral mesotelencephalic 6-hydroxydopamine (6-OHDA) injections revealed reduced binding of [3H]SCH23390 to D1 receptors in the striatum ipsilateral to the neurotoxin as well as increased binding of [3H]spiroperidol to D2 receptors in that hemisphere. These opposite influences of injury on the dopamine receptor subtypes occurred in rats sacrificed at 2 weeks or 11 months postoperatively, but neither change was evident at 4 days postoperatively. Equilibrium saturation analysis performed on rats sacrificed at 8 weeks postoperatively indicated that D1 and D2 receptor changes reflected alteredBmax values withoutKD modifications. Topographic analysis of the D1 decline by quantitative autoradiography revealed that the D1 decrease was greater in dorsal striatum than ventrally. Those striatal regions that showed greater declines in D1 density correspondingly had the greater losses of [3H]mazindol binding after the denervation, suggesting that the decline of D1 binding is a postsynaptic consequence of the reduced mesostriatal dopaminergic innervation. The findings indicate opposite influences of injury on D2 and D1 receptor levels and raise important questions concerning the mechanism by which 6-OHDA injection affects the D1 sites.

References (49)

  • MarshallJ.F.

    Somatosensory inattention after dopamine depleting 6-OHDA injections: spontaneous recovery and pharmacological control

    Brain Research

    (1979)
  • MarshallJ.F. et al.

    Supersensitivity to apomorphine following destruction of the ascending dopamine neurons: quantification using the rotational model

    Eur. J. Pharmacol.

    (1977)
  • MishraR.K. et al.

    Supersensitivity in rat caudate nucleus: effects of 6-hydroxydopamine on the time course of dopamine receptor and cyclic AMP changes

    Brain Research

    (1980)
  • NeveK.A. et al.

    The effects of denervation and chronic haloperidol treatment on neostriatal dopamine receptor density are not additive

    Neurosci. Lett.

    (1984)
  • NeveK.A. et al.

    Quantitative analysis of [3H]spiroperidol binding to rat forebrain sections: plasticity of neostriatal dopamine receptors after nigrostriatal injury

    Brain Research

    (1984)
  • NeveK.A. et al.

    Plasticity of neostriatal dopamine receptors after nigrostriatal injury: relationship to recovery of sensorimotor functions and behavioral supersensitivity

    Brain Research

    (1982)
  • PorcedduM.L. et al.

    6-Hydroxydopamine-induced degeneration of nigral dopamine neurons: differential effect on nigral and striatal D-1 dopamine receptors

    Life Sci.

    (1987)
  • PorcedduM.L. et al.

    [3H]SCH23390 binding sites increase after chronic blockade of D-1 dopamine receptors

    Eur. J. Pharmacol.

    (1985)
  • RaismanR. et al.

    Binding of [3H]SCH 23390 to D-1 receptors in the putamen of control and parkinsonian subjects

    Eur. J. Pharmacol.

    (1985)
  • SavastaM. et al.

    Different plasticity changes in D1 and D2 receptors in rat striatal subregions following impairment of dopaminergic transmission

    Neurosci. Lett.

    (1988)
  • SavastaM. et al.

    Autoradiographic localization of D1 dopamine receptors in the rat brain with [3H]SCH 23390

    Brain Research

    (1986)
  • SchoenfeldR. et al.

    Altered response to apomorphine in 6-hydroxydopamine-treated rats

    Eur. J. Pharmacol.

    (1972)
  • StauntonD.A. et al.

    Dopamine receptor changes following destruction of the nigrostriatal pathway: lack of a relationship to rotational behavior

    Brain Research

    (1981)
  • AltarC.A. et al.

    Picomolar affinity of125I-SCH 23982 for D1 receptors in brain demonstrated with digital subtraction autoradiography

    J. Neurosci.

    (1987)
  • Cited by (0)

    *

    Present address: Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, U.S.A.

    View full text